Diaceutics hopes to ‘super charge’ its offering in US market after CMS approval

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 77%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Irish data analytics company will receive US claims data more frequently via IrishTimesBiz

The data will help to provide enhanced insight into the testing landscape for precision medicine through Diaceutics’ DXRX diagnostic commercialisation platform. The increased frequency of data feed will will help Diaceutics’s pharma and diagnostic clients to understand the evolving testing landscape in almost real time, which should help drive faster access to the right treatment.said the step up in data access would help “supercharge” its service in the market.

“The most competitive companies in the diagnostic data space are those that not only can integrate very different large data sets but can deliver near real time customer insights,” he said.

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 6. in RU
 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

Россия Последние новости, Россия Последние новости